It has been one month since we welcomed NICO Corporation to Stryker! On September 20, it was announced that we completed the acquisition of NICO Corporation, a privately held company providing a systematic approach to minimally invasive surgery for tumor and intracerebral hemorrhage (ICH) procedures. This acquisition further strengthens our commitment to neurotechnology through tumor and stroke care. Together we are advancing neurosurgery and transforming lives! Learn more: https://lnkd.in/gpDA9Kw9 Follow us at Stryker Neurosurgical for more information and updates.
NICO Corporation’s Post
More Relevant Posts
-
With the AO CMF Start-up Grants, AO CMF supports projects in a wide range of research fields including unconventional and novel projects. It favours projects related to basic, preclinical, and clinical research in the fields of trauma and reconstruction in craniomaxillofacial (CMF) surgery. The grant provides, stand-alone seed funding up to CHF 50,000 with a maximum duration of 2 years, to support innovative research projects. Read more and apply by February 17, 2025 🔗 https://brnw.ch/21wP0I6
-
-
Curious about how advanced brain and pituitary surgeries are performed? Endoscopic Endonasal Surgery is one of the most common procedures at Pacific Neuroscience Institute, offering a minimally invasive option for patients with brain, pituitary, and skull base tumors. This 3D animation showcases the cutting-edge techniques used in treating both benign and malignant tumors, ensuring comprehensive care with faster recovery. Watch now to learn more about our innovative approach. #BrainTumor #EndoscopicSurgery #PituitaryTumor #PNI
-
In a groundbreaking study, #TeamUHN researchers found that molecular profiling of one of the most common brain tumours can help identify the best treatment results. "One of the most challenging clinical decisions to make in the care of meningioma patients is deciding which patients should receive radiation treatment after surgery for their tumour," says Dr. Gelareh Zadeh, co-supervisor of this study and co-director of UHN's Krembil Research Institute. The findings from this study highlight the potential for molecular profiling to refine surgical and radiotherapy decision-making, and improve patient outcomes in the future. Read more about the research 👇 https://bit.ly/3MgrGOM
-
-
How can AI help with neurosurgery or spinal surgery? María Inmaculada Rodríguez Ponce from Snke OS, a Brainlab Company tells us about how with a combination of data analysis, anatomical segmentation and deformable co-registration we can create a specific synthetic tissue model, known as digital twin, that can support cancer surgeries. #AISymposium #wirsindCERFA #CERFASymposium2024
-
-
Truly a transformational device
We are excited to share that our portfolio company MMI - Medical Microinstruments, Inc. has been named among “The Best Inventions of 2024” by TIME magazine! We are proud to partner with #MMI on its journey to redefine the boundaries of microsurgery with its revolutionary robotic system that is transforming patient care in areas such as breast cancer reconstruction, lymphatic surgery, and neurosurgery. Congratulations to Mark Toland, MMI CEO and BioStar Managing Director, and the entire MMI team! Learn more here: https://lnkd.in/eQs2EBit (Image source, TIME Magazine).
-
-
Associate Professor and Thoracic Surgeon focusing on Patient Reported Outcomes Research
Results from this survey will help us identifying strategies to improve patient participation in perioperative care and patient-reported outcomes Lung Cancer Europe European Society of Thoracic Surgeons
Have you, or someone you know, had thoracic surgery for lung cancer? We’re inviting individuals who have personally undergone thoracic surgery to share their experiences by completing a quick, anonymous survey: https://lnkd.in/dUz6hWZk The insights from this survey will help improve care and support for others going through similar procedures. Led by surgeons at the University of Hull and partner institutions across Europe, the project aims to better understand the needs of patients during their surgical journey and enhance decision-making processes. Thank you for your support—it really makes a difference. #LungCancerSurgery #ThoracicSurgery #LungCancerTreatment
-
-
🚨A call for papers! 🚨 Are you researching cardiac ablation and interested in having your work published? 👀 Interdisciplinary CardioVascular and Thoracic Surgery (ICVTS) is inviting submissions for a special focus on ‘Cardiac Ablation: Current Trends, Challenges and Potentials’. This issue focuses on exploring current trends, challenges and innovative approaches in cardiac ablation, aiming to improve both the efficacy and safety of these procedures. 🌟 Submissions are open! 🌟 Find out more and submit your paper 👇 https://lnkd.in/dxRd6QZy
-
Congratulations to Cinira Diogo, PhD, D. ABNM, Brooke Callahan, Au.D. DABNM, and the entire team behind the recent published study in the Journal of Neurointerventional Surgery on the impact of intraoperative neuromonitoring (#IONM) on #TCAR surgeries. With findings showing IONM's high sensitivity (100%) and specificity (99.2%) in predicting patient outcomes, it's clear that this monitoring technique is a crucial tool for TCAR surgeries. It's exciting to see such impactful research contributing to the field. This achievement exemplifies how teamwork, dedication, and innovative thinking can lead to advancements that benefit patients and practitioners alike. For an in-depth look at their findings, you can find the article here. https://lnkd.in/gMewitri You can also write the author Dr. Diogo for a copy at ciniraa.diogo@gmail.com #neurointervention #neurophysiology #neurovascular #ASNM #vascularsurgery
-
🌍 AI Model Quickly Identifies Residual Brain Tumors During Surgery AI Model Detects Brain Tumors in 10 Seconds 🧠⏱️ FastGlioma improves surgical outcomes by identifying residual tumors more accurately than traditional methods. https://lnkd.in/dY34HyzY #AI #BrainTumor #Surgery #HealthTech #MedicalInnovation
-
Founder, Jenkins NeuroSpine -- Founder, Greenwich Neurological Institute -- CEO, Neurotect LLC -- Advisor, Caelum LLC
Just uploaded my short (3 min) talk on my minimally invasive approach to removing and stabilizing spinal tumors causing MESCC (metastatic epidural spinal cord compression) that avoids large procedures, extensive spinal instrumentation, but give equivalent to superior outcomes for the patient by reducing complications, making the procedure easier to tolerate, and speeding use of adjuvant therapy. This was presented September 2024 at the 2024 SMISS (Society for Minimally Invasive Spinal Surgery) in Las Vegas. More on this subject coming, as we've submitted for publication our full article, but this is a bit of a "teaser trailer" of bigger results to come, including a soon-to-be-released longer version of this talk that I just gave at the 2024 American College of Surgeons Clinical Congress in San Francisco. https://lnkd.in/eXvHfRZt
